Histology as a treatment effect modifier in advanced non-small cell lung cancer: A systematic review of the evidence

ABSTRACT Background and objective: We conducted a systematic review of prospective, randomized, controlled trials (RCT) to examine whether histology had a treatment modifying effect (TME) on the efficacy outcomes of chemotherapeutic agents in patients with advanced (stage IIIB‐IV) non‐small cell lu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respirology (Carlton, Vic.) Vic.), 2011-11, Vol.16 (8), p.1210-1220
Hauptverfasser:	STANDFIELD, LACHLAN, WESTON, ADÈLE R., BARRACLOUGH, HELEN, VAN KOOTEN, MAXIMILIANO, PAVLAKIS, NICK
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carboplatin - administration & dosage Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Cisplatin - administration & dosage Clinical Trials, Phase III as Topic Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Evidence-Based Medicine Female Glutamates - administration & dosage Guanine - administration & dosage Guanine - analogs & derivatives histology/cytology Humans lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Pemetrexed Randomized Controlled Trials as Topic Reproducibility of Results systematic review Taxoids - administration & dosage treatment modifying effect
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!